Intravitreal bevacizumab vs. combination of intravitreal bevacizumab plus macular photocoagulation in clinically significant diabetic macular edema: 6 months results of a randomized clinical trial

Iranian Journal of Ophthalmology

Volumn 22, Issue 1, 2010, Pages 21-26

  Faghihi, Hooshang ^a,b   Esfahani, Mohammad Riazi ^a,b   Harandi, Zahra Aalami ^a   Madani, Shahram ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NOOR EYE HOSPITAL   (Iran)

Author keywords

Bevacizumab; Clinically significant macular edema; Diabetic macular edema; Macular photocoagulation

Indexed keywords

EID: 77949554127     PISSN: 2345279x     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Richter B, Kohner E. Medical interventions for diabetic retinopathy. Evidence-based Ophthalmology. London: BMJ Books; 2004:331-40.
2. Klein R, Kelin BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy IV. Diabetic macular edema. Ophthalmology 1984;91(12):1464-74.
3. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414(6865):782-7.
4. Early Treatment Diabetic Retinopathy study Research group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy Report number 1. Arch Ophthalmol 1985; 103:1796-806.
5. Bresnick GH. Diabetic maculopathy: A critical review highlighting diffuse macular edema. Ophthalmology 1983;90(11):1301-17.
6. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25(4):581-611.
7. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in vitreous of eyes with proliferative diabetic retinopathy. AM J Ophthalmol 1994;118(4):445-50.
8. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
9. Tolentino MJ, McLeod DS, Taomoto M, et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J ophtholmol 2002;133(3):373-85.
10. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996;103(11):1820-8.
11. Arevalo JF, Fromow-Guerrea J, Quiroz-Mercado H, et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114(4):743-50.
12. Pieramici DJ, Avery RL, Castellarin AA, et al. Case of anterior uveitis after intravitreal injection of bevacizumab. Retina 2006;26(7):841-2.
13. Diabetes Control and Complications Trial Research Group. N. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329: 977-86.
14. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
15. Chun DW, Heier JS, Topping TM, et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 2006;113(10):1076-12.
16. Macugen Diabetic Retinopathy Study Group. A phase 2 randomized double-masked trial of Pegeptanib, and anti-vascular endothelial growth factor aptamer for diabetic macular edema. Ophthalmology 2005;112:1747-57.
17. Faghihi H, Roohipoor R, Mohammadi SF, et al. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. Eur J Ophthalmol 2008;18(6):941-8.
18. Soheilian M, Ramezani A, Bijanzedeh B, et al. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina 2007;27(9):1187-95.
19. Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology 2009;116(6):1142-50.
20. Diabetic Retinopathy Clinical Research Network. A phase II RCT of IVB for DME. Ophthalmology 2007;114:1860-7.
21. Diabetic Retinopathy Clinical Research Network. A Randomized trial comparing intravitreal Triamcinolone Acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-59.